Y Ohata
Overview
Explore the profile of Y Ohata including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
34
Citations
127
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kojima Y, Takeyabu K, Kimura M, Matunaga A, Arisato H, Ohata Y, et al.
QJM
. 2021 Jun;
114(9):673-674.
PMID: 34129045
No abstract available.
2.
Ohata Y, Takeyari S, Nakano Y, Kitaoka T, Nakayama H, Bizaoui V, et al.
Osteoporos Int
. 2020 Apr;
31(6):1185.
PMID: 32246166
The original article has been corrected.
3.
Ohata Y, Takeyari S, Nakano Y, Kitaoka T, Nakayama H, Bizaoui V, et al.
Osteoporos Int
. 2019 Aug;
30(11):2333-2342.
PMID: 31363794
Introduction: Most cases of osteogenesis imperfecta (OI) are caused by mutations in COL1A1 or COL1A2, which encode α chains of type I collagen. However, mutations in at least 16 other...
4.
Makino H, Tanaka A, Asakura K, Koezuka R, Tochiya M, Ohata Y, et al.
Diabet Med
. 2019 Jul;
36(12):1621-1628.
PMID: 31335979
Aim: To test the hypothesis that the addition of a glucagon-like peptide-1 receptor agonist that can decrease glucose levels without increasing the hypoglycaemia risk will achieve appropriate glycaemic control during...
5.
Makino H, Tanaka A, Hosoda H, Koezuka R, Tochiya M, Ohata Y, et al.
Diabet Med
. 2016 May;
33(12):1737-1743.
PMID: 27150701
Aim: To compare the effects of the basal insulin analogues glargine and detemir on endothelial function and adipocytokine levels in people with Type 2 diabetes. Methods: We studied 32 people...
6.
Kishimoto I, Makino H, Ohata Y, Tamanaha T, Tochiya M, Kusano K, et al.
Diabet Med
. 2015 Jul;
33(8):1118-24.
PMID: 26173591
Aims: To examine if a simple biomarker can identify people with diabetes who are at high risk of atrial fibrillation. Methods: A retrospective cohort study was conducted at a single...
7.
Tsuge K, Ohata Y, Shoda M
Antimicrob Agents Chemother
. 2001 Nov;
45(12):3566-73.
PMID: 11709341
Surfactin is a cyclic lipopeptide biosurfactant. Transposon mutagenesis was performed in Bacillus subtilis strain 168, and a surfactin-susceptible mutant, strain 801, was isolated. Analysis of the region of insertion revealed...
8.
Ohata Y, Harada T, Fujii A, Yoshida S, Iwabe T, Terakawa N
Mol Hum Reprod
. 2001 Jun;
7(7):665-70.
PMID: 11420390
We have investigated the possible roles of oncostatin M (OSM), which is a member of the interleukin-6 family of cytokines, in endometrial and endometriotic stromal cell growth. Endometrial and endometriotic...
9.
Ohata Y, Amagai M, Ishii K, Hashimoto T
J Dermatol Sci
. 2001 Jan;
25(1):64-71.
PMID: 11154866
In pemphigus vulgaris (PV) and pemphigus foliaceus (PF), most of the autoantibodies are directed against the extracellular domains of desmoglein 1 (Dsg1) or Dsg3, and those antibodies are proved to...
10.
Ohata Y, Harada T, Ito M, Yoshida S, Iwabe T, Terakawa N
Gynecol Obstet Invest
. 2000 Oct;
50(3):186-8.
PMID: 11014952
The aim of our study was to determine the efficacy of postponing administration of human chorionic gonadotropin while continuing daily gonadotropin-releasing hormone agonist therapy ('coasting') to prevent the occurrence of...